Verve Therapeutics Stock Soars 24% on Expanded Eli Lilly Partnership
November 02, 2023: Verve Therapeutics' (NASDAQ: VRV) stock price jumped 24% on Tuesday after the company announced an expanded partnership with Eli Lilly
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds